Home LiteratureArticle Details
PMID: 17998940 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.

Oncogene ·Vol. 27 ·No. 18 ·2008-04-17 ·Pages 2575-82

Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA

Abstract

Human papillomaviruses (HPVs) are involved in the pathogenesis of cancer of the cervix (CaCx). MicroRNA (miRNA) expression analysis using Ambion (Austin, TX, USA) arrays showed that three miRNAs were overexpressed and 24 underexpressed in cervical cell lines containing integrated HPV-16 DNA compared to the normal cervix. Furthermore, nine miRNAs were overexpressed and one underexpressed in integrated HPV-16 cell lines compared to the HPV-negative CaCx cell line C-33A. Based on microarray and/or quantitative real-time PCR and northern blot analyses, microRNA-218 (miR-218) was specifically underexpressed in HPV-positive cell lines, cervical lesions and cancer tissues containing HPV-16 DNA compared to both C-33A and the normal cervix. Expression of the E6 oncogene of high-risk HPV-16, but not that of low-risk HPV-6, reduced miR-218 expression, and conversely, RNA interference of E6/E7 oncogenes in an HPV-16-positive cell line increased miR-218 expression. We also demonstrate that the epithelial cell-specific marker LAMB3 is a target of miR-218. We also show that LAMB3 expression is increased in the presence of the HPV-16 E6 oncogene and this effect is mediated through miR-218. These findings may contribute to a better understanding of the molecular mechanisms involved in cervical carcinogenesis.

MeSH Terms
Biomarkers, Tumor/biosynthesis,genetics Cell Adhesion Molecules/biosynthesis,genetics Cell Transformation, Viral/genetics Female Gene Expression Profiling Gene Expression Regulation, Neoplastic HeLa Cells Human papillomavirus 16/genetics,metabolism Human papillomavirus 6/genetics,metabolism Humans MicroRNAs/biosynthesis,genetics Oligonucleotide Array Sequence Analysis Oncogene Proteins, Viral/antagonists & inhibitors,biosynthesis,genetics Papillomavirus E7 Proteins Papillomavirus Infections/genetics,metabolism RNA, Neoplasm/biosynthesis,genetics Repressor Proteins/antagonists & inhibitors,biosynthesis,genetics Uterine Cervical Neoplasms/genetics,metabolism,virology
Chemicals
Biomarkers, Tumor Cell Adhesion Molecules E6 protein, Human papillomavirus type 16 MicroRNAs Oncogene Proteins, Viral Papillomavirus E7 Proteins RNA, Neoplasm Repressor Proteins kalinin oncogene protein E7, Human papillomavirus type 16
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Martinez I
Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Gardiner A S
Board K F
Monzon F A
Edwards R P
Khan S A
References (33)
33 references, click to expand
  1. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation.
    Oncogene. 1999 Sep 30;18(40):5487-96 PMID: 10523825
  2. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16.
    Cancer Res. 2002 Dec 1;62(23):6959-65 PMID: 12460913
  3. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle.
    Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10002-7 PMID: 10944189
  4. Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells.
    EMBO J. 1993 May;12(5):1847-52 PMID: 8387914
  5. MicroRNA biogenesis: coordinated cropping and dicing.
    Nat Rev Mol Cell Biol. 2005 May;6(5):376-85 PMID: 15852042
  6. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity.
    Rev Med Virol. 2006 Mar-Apr;16(2):83-97 PMID: 16287204
  7. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas.
    Eur J Cancer. 2007 Jan;43(2):415-32 PMID: 17079134
  8. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.
    Cell. 2005 Jan 14;120(1):15-20 PMID: 15652477
  9. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
    Methods. 2001 Dec;25(4):402-8 PMID: 11846609
  10. miRBase: microRNA sequences, targets and gene nomenclature.
    Nucleic Acids Res. 2006 Jan 1;34(Database issue):D140-4 PMID: 16381832
  11. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription.
    EMBO J. 1992 Aug;11(8):3045-52 PMID: 1379175
  12. Immunohistochemical expression of laminin-5 in cervical intraepithelial neoplasia.
    Gynecol Oncol. 2003 Jun;89(3):391-4 PMID: 12798700
  13. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.
    Nature. 2003 Feb 6;421(6923):639-43 PMID: 12571598
  14. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
    Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2014-24 PMID: 16609010
  15. Human papillomavirus immortalization and transformation functions.
    Virus Res. 2002 Nov;89(2):213-28 PMID: 12445661
  16. microRNAs exhibit high frequency genomic alterations in human cancer.
    Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9136-41 PMID: 16754881
  17. Laminin-5 beta3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity.
    Neoplasia. 2004 Sep-Oct;6(5):468-79 PMID: 15548355
  18. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation.
    J Virol. 2006 May;80(9):4249-63 PMID: 16611884
  19. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
    Cancer Res. 2002 Oct 15;62(20):5874-80 PMID: 12384551
  20. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.
    Mol Cancer. 2006 Jul 19;5:29 PMID: 16854228
  21. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.
    EMBO J. 1991 Dec;10(13):4129-35 PMID: 1661671
  22. Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses.
    J Infect Dis. 1994 Nov;170(5):1096-9 PMID: 7963700
  23. MicroRNA-cancer connection: the beginning of a new tale.
    Cancer Res. 2006 Aug 1;66(15):7390-4 PMID: 16885332
  24. The role of the E6-p53 interaction in the molecular pathogenesis of HPV.
    Oncogene. 1999 Dec 13;18(53):7690-700 PMID: 10618709
  25. Laminin-5 as a marker of invasiveness in cervical lesions.
    J Natl Cancer Inst. 1999 Nov 3;91(21):1882-7 PMID: 10547396
  26. The colorectal microRNAome.
    Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3687-92 PMID: 16505370
  27. Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability.
    Cancer Res. 2003 Jan 15;63(2):476-83 PMID: 12543805
  28. HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation.
    Oncogene. 1996 Jun 6;12(11):2325-30 PMID: 8649772
  29. Papillomaviruses and cancer: from basic studies to clinical application.
    Nat Rev Cancer. 2002 May;2(5):342-50 PMID: 12044010
  30. Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells.
    J Virol. 2006 Sep;80(18):8940-50 PMID: 16940506
  31. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
    Oncogene. 2002 Sep 5;21(39):6041-8 PMID: 12203116
  32. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines.
    J Gen Virol. 1999 Jul;80 ( Pt 7):1725-1733 PMID: 10423141
  33. Properties of a non-tumorigenic human cervical keratinocyte cell line.
    Int J Cancer. 1989 Apr 15;43(4):672-6 PMID: 2467886
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
1476-5594
Published
2008-04-17
Epub
2007-00-12
Pages
2575-82
Language
English
Region
England
NLM ID
8711562
PMCID
PMC2447163
Subset
IM
Grants
NIDCD NIH HHS · DC016406 · United States
NIDCR NIH HHS · DE019028 · United States
NIGMS NIH HHS · 5T32GM065100 · United States
NIDCR NIH HHS · F31 DE019028-01A1 · United States
NIGMS NIH HHS · T32 GM065100 · United States
NIDCR NIH HHS · F31 DE019028 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com